Several studies have shown that plasma p-tau isoforms, such as p-tau181, p-tau217, and p-tau231, are highly accurate and specific for the detection of PET-confirmed Aβ and tau pathology across the clinical AD continuum in European and American populations; thus, these are recognized as the most promising plasma biomarkers in detecting AD [4–6]. Here, MAPT is linked to Alzheimer disease.